Improved access to treatment and prevention of blindness globally

Age-related macular degeneration (AMD) is a leading cause of blindness globally. With an aging population, the number of people with AMD is estimated to reach 243 million worldwide by 2030. AMD first presents as blurred, distorted vision, difficulty seeing in dim lighting, and reading problems. It can eventually lead to reduced independence and quality of life.